Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : AAV00404Z
Serotype : AAV Serotype 8 Storage : -80 ℃
Titer: Size:
| Cat. No. | AAV00404Z |
| Description | Premade self-complementary AAV particles in serotype 8 (scAAV8) express GFP reporter gene from the CAG promoter. |
| Gene | GFP |
| Serotype | AAV Serotype 8 |
| Titer | Varies lot by lot, typically ≥1x10^12 GC/mL |
| Size | Varies lot by lot, for example, 30 μL, 100 μL, 500 μL etc. |
| Storage | Store at -80℃. Avoid multiple freeze/thaw cycles. |
| Shipping | Frozen on dry ice |
| Summary | Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots. |
| Endotoxin | Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance. |
| Purity | AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE. |
| Sterility | The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth. |
| Transducibility | Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities. |
| Empty vs. Full Capsids | Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods. |
| Target Gene | GFP |
Adeno-associated viruses (AAV) belong to the parvovirus family. They are dependent viruses that require a helper virus, such as adenovirus (Ad), for replication. Once inside the nucleus of the target cell, the single-stranded (ss)DNA genome of AAV is converted to double-stranded (ds)DNA and then transcribed. Different AAV serotypes have been isolated from humans and non-human primates, but none have been associated with disease. AAV vectors have been developed for in vivo gene transfer that have deleted viral sequences encoding regulatory sequences and capsid proteins but still contain long terminal repeats, and different serotypes have been used to target specific tissues, such as serotype 1 for muscle, serotype 8 for liver, or serotypes 5 and 7 for brain.
First-generation AAV vectors carrying ssDNA genomes, also called ssAAV vectors, have been tested preclinically and clinically for the treatment of a variety of genetic diseases. Clinical trials have shown efficacy in patients with inherited blindness who received ssAAV serotype 2 vectors. Studies have shown that conversion of ssDNA to dsDNA is rate limiting for the onset and level of transgene expression in ssAAV vectors. Second generation AAV vectors with ds genomes, also called self-complementary AAV (scAAV) vectors, have been developed. ScAAV vectors produce higher levels of transgene product compared to ssAAV vectors. In addition, the onset of transgene product expression is also faster. Early clinical trials using scAAV8 vectors expressing human factor IX have shown results in partial correction of hemophilia B.
The effectiveness of adeno-associated virus (AAV)-based gene therapy is often limited by the presence of AAV neutralizing antibodies (NAbs). Existing assays are inconsistent across laboratories and cell-dependent, challenging their general applicability. Here, researchers present the AAV homology-directed repair (HDR) assay, which leverages the CRISPR-Cas9 system to provide a precise and sensitive method for detecting AAV NAbs. The assay employs a promoter-less AAV HDR vector integrated into electroporated cells, facilitating stable expression of a quantifiable fluorescent reporter gene and subsequent NAb titer assessment. Comparative evaluations demonstrated that the AAV-HDR approach outperformed the conventional AAV overexpression (AAV-OE) assay in terms of sensitivity and consistency. Crucially, it produced consistent results across a variety of cell lines, suggesting its potential to become a universal standard for NAb titer measurement. Researchers further validated the AAV-HDR titration assay by comparing it to the established NT50 assay. Notably, the AAV-HDR approach showed strong correlation with both the AAV-OE assay and the NT50 NAb titer values and demonstrated higher efficacy in identifying low-titer antibodies compared with the NT50 approach.
Given the growing promise of AAV8-based liver gene therapy, the researchers focused their research on AAV8 vectors. Unlike AAV8 vectors, self-complementary AAV (scAAV) vectors are known for their superior in vitro transduction efficiency. Unlike single-stranded AAV vectors, they have the advantage of not requiring the synthesis of the second strand before initiating transcription. The researchers used the scAAV8-CAG-GFP vector to introduce it into the K562 leukemia cell line (Figure 1A). FACS analysis of K562 cells after transduction at increasing MOIs showed a gradual increase in GFP expression from 7% to more than 80% (Figures 1B, C). To describe the relationship between MOI and GFP%, a standard curve was constructed. Notably, both binomial and logistic regressions showed robust agreement between GFP% and AAV virion counts. Given the slightly higher R2 value of the binomial regression (over 0.99), it was chosen for subsequent evaluation (Figure 1D). These data highlight the effectiveness of AAV8 vectors in transducing K562 cells and the positive correlation between MOI and transduction efficiency.
Figure 1. Correlation of AAV vector MOI with GFP expression post-transduction. (Li G, et al., 2024)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The high viral titers and purity levels we obtained were beyond our expectations. Creative Biogene has ensured a quality product that meets our rigorous standards for research.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.